Monsanto Co (MON)

116.02
NYSE : Basic Materials
Prev Close 116.02
Day Low/High 0.00 / 0.00
52 Wk Low/High 88.76 / 116.60
Avg Volume 2.04M
Exchange NYSE
Shares Outstanding 438.81M
Market Cap 50.68B
EPS 3.00
P/E Ratio 26.74
Div & Yield 2.16 (1.90%)

Latest News

Week in Review: Slight Losses as Week Ends With Worries Over Syria, Jobs

Week in Review: Slight Losses as Week Ends With Worries Over Syria, Jobs

Wall Street ended the first week of the second quarter lower than it started.

Wall Street Turns Red in Final Hour After Fed Commits to Tightening

Wall Street Turns Red in Final Hour After Fed Commits to Tightening

Wall Street ends lower, falling into the red in the final hour, after the Federal Reserve's commits to further monetary tightening this year.

Monsanto Delivers in Second Quarter, Continues Return to Growth

Monsanto Delivers in Second Quarter, Continues Return to Growth

Monsanto reported better than expected 2017 earnings results.

Stocks Lose Gains After Fed Commits to Reduce Balance Sheet, Increase Rates

Stocks Lose Gains After Fed Commits to Reduce Balance Sheet, Increase Rates

Stocks lose highs Wednesday after the minutes were released from the Federal Reserve's most recent meeting.

Midday Report: Monsanto Smashes Quarterly Estimates; ADP Foreshadows Strong Jobs Number

Midday Report: Monsanto Smashes Quarterly Estimates; ADP Foreshadows Strong Jobs Number

Wall Street clocked solid gains after a strong reading on private payrolls bode well for the official jobs number out at the end of the week.

Stocks Extend Gains After Strong ADP Report Points to Solid U.S. Jobs Number

Stocks Extend Gains After Strong ADP Report Points to Solid U.S. Jobs Number

Stocks extend gains on Wednesday after a strong reading on private payrolls foreshadows a solid U.S. jobs number for March.

Monsanto Continues Return To Growth In Fiscal Year 2017 With Strong Second Quarter And First Half Results; Updates Outlook For Full Year EPS To High End Of Guidance Range

Monsanto Continues Return To Growth In Fiscal Year 2017 With Strong Second Quarter And First Half Results; Updates Outlook For Full Year EPS To High End Of Guidance Range

With half of its fiscal year 2017 complete, Monsanto Company (NYSE: MON) announced strong second quarter and first six months results.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures are mixed Wednesday as investors await the release of the minutes from the Federal Reserve meeting in March, and a snapshot on the U.S. labor market.

Market Recon: Get Ready for the Unofficial Start of Earnings Season

Market Recon: Get Ready for the Unofficial Start of Earnings Season

Overall expectations for the S&P 500 are for earnings increase of over 9% year on year for the first quarter.

EU Approves ChemChina's $43 billion Acquisition of Syngenta

EU Approves ChemChina's $43 billion Acquisition of Syngenta

ChemChina and Switzerland's Syngenta win conditional approval from the European Commission for their $43 billion Wednesday.

What to Watch Wednesday: Walgreens, Bed Bath & Beyond Report Earnings

What to Watch Wednesday: Walgreens, Bed Bath & Beyond Report Earnings

On Wednesday, April 5, investors await quarterly earnings from Walgreens WBA, Bed Bath & Beyond BBBY and Monsanto MON.

ChemChina Gets FTC OK to Snap Up Syngenta

ChemChina Gets FTC OK to Snap Up Syngenta

ChemChina must sell its U.S. paraquat, abamectin and chlorothalonil crop protection businesses to California agrochemical company AMVAC.

Jim Cramer: Watch Monsanto's Earnings for Status of Bayer Deal

Jim Cramer: Watch Monsanto's Earnings for Status of Bayer Deal

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said investors should watch Monsanto's MON earnings for the status of its pending merger with Bayer.

Week Ahead: Wall Street Is Near Records but as 2Q Begins Trump Threatens Stability

Week Ahead: Wall Street Is Near Records but as 2Q Begins Trump Threatens Stability

Wall Street enters a new week and new quarter on Monday with stocks at or close to all-time records set at the beginning of March.

Week Ahead: The GOP Girds for Battle ... With Itself

Week Ahead: The GOP Girds for Battle ... With Itself

Wall Street's pro-business agenda could suffer collateral damage, as infighting among Republicans grows worse. Here's how to trade in the days ahead.

Ignore the Tweets! Merger Enforcement in Trump Era

Ignore the Tweets! Merger Enforcement in Trump Era

Antitrust experts say DOJ and FTC will need to tune out the president's Twitter feed.

So Far So Good : Cramer's 'Mad Money' Recap (Friday 3/31/17)

So Far So Good : Cramer's 'Mad Money' Recap (Friday 3/31/17)

The amazing first quarter didn't rely just on Trump.

Monsanto Company Sets Webcast And Analyst Call For Second-Quarter 2017 Earnings

Monsanto Company Sets Webcast And Analyst Call For Second-Quarter 2017 Earnings

Monsanto Company (NYSE: MON) announced it will issue the company's financial results for its fiscal 2017 second quarter on Wednesday, April 5, 2017, prior to market open.

Activist Investor Marcato Rebukes Buffalo Wild Wings Director Nominations

Activist Investor Marcato Rebukes Buffalo Wild Wings Director Nominations

Investment manager Marcato Capital Management says the changes to the board 'do not go far enough,' even though one of the nominees came from its dissident slate.

Lawsuit Accuses Monsanto of Ghostwriting Scientific Reports

Lawsuit Accuses Monsanto of Ghostwriting Scientific Reports

Monsanto's former VP, Michael Taylor was head of the FDA under Obama.

Novice Trade: Materials Select Sector ETF

Novice Trade: Materials Select Sector ETF

If you think the chemicals sector is primed for further highs, this is a good way to play.

Bayer, Monsanto Initiate $2.5 Billion Asset Sale

Bayer, Monsanto Initiate $2.5 Billion Asset Sale

The move is intended to make their $66 billion merger more palatable to regulators.

European Stocks Fall on Earnings Upsets, Politics

European Stocks Fall on Earnings Upsets, Politics

European stocks were weaker and bonds higher as unease returned to markets.

Bayer Offers Further Detail on Financing Monsanto Takeover

Bayer Offers Further Detail on Financing Monsanto Takeover

Bayer isn't expecting their deal for Monsanto to be derailed by regulatory issues, despite recent delays.

Bayer's Cautious 2017 Outlook Causes Stock to Slump

Bayer's Cautious 2017 Outlook Causes Stock to Slump

Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.

Global Financial News: Earnings In The Spotlight

Global Financial News: Earnings In The Spotlight

A week full of financial reports continues, as Bayer and Lloyds post full-year earnings

European Stocks Extend Gains as Economic Data Continues to Impress

European Stocks Extend Gains as Economic Data Continues to Impress

European stocks tested multi-month highs Wednesday after better-than-expected business sentiment data from Germany and an upgrade to the fourth quarter pace of growth in the United Kingdom.